It is therefore important to study and understand the hereditary mutations affecting the BRCA2 protein throughout the human population in order to increase the ability of clinicians to predict and treat cancers related to hypomorphic or nonfunctional BRCA2 alleles. This evidence concerns the gene BRCA2 and cancer.